Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages
Copyright © 2016 Elsevier B.V. All rights reserved..
Inflammatory response plays an important role in the activation and progress of many debilitating diseases. Natural products, like cannabidiol, a constituent of Cannabis sativa, and moringin, an isothiocyanate obtained from myrosinase-mediated hydrolysis of the glucosinolate precursor glucomoringin present in Moringa oleifera seeds, are well known antioxidants also endowed with anti-inflammatory activity. This is due to a covalent-based mechanism for ITC, while non-covalent interactions underlie the activity of CBD. Since these two mechanisms are distinct, and the molecular endpoints are potentially complementary, we investigated in a comparative way the protective effect of these compounds alone or in combination on lipopolysaccharide-stimulated murine macrophages. Our results show that the cannabidiol (5μM) and moringin (5μM) combination outperformed the single constituents that, at this dosage had only a moderate efficacy on inflammatory (Tumor necrosis factor-α, Interleukin-10) and oxidative markers (inducible nitric oxide synthase, nuclear factor erythroid 2-related factor 2, nitrotyrosine). Significant upregulation of Bcl-2 and downregulation of Bax and cleaved caspase-3 was observed in cells treated with cannabidiol-moringin combination. Treatment with the transient receptor potential vanilloid receptor 1 antagonist was detrimental for the efficacy of cannabidiol, while no effect was elicited by cannabinoid receptor 1 and cannabinoid receptor 2 antagonists. None of these receptors was involved in the activity of moringin. Taken together, our in vitro results testify the anti-inflammatory, antioxidative, and anti-apoptotic effects of the combination of cannabidiol and moringin.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:112 |
---|---|
Enthalten in: |
Fitoterapia - 112(2016) vom: 31. Juli, Seite 104-15 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rajan, Thangavelu Soundara [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 13.02.2017 Date Revised 21.03.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.fitote.2016.05.008 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM260654671 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM260654671 | ||
003 | DE-627 | ||
005 | 20231224193849.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.fitote.2016.05.008 |2 doi | |
028 | 5 | 2 | |a pubmed24n0868.xml |
035 | |a (DE-627)NLM260654671 | ||
035 | |a (NLM)27215129 | ||
035 | |a (PII)S0367-326X(16)30115-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rajan, Thangavelu Soundara |e verfasserin |4 aut | |
245 | 1 | 0 | |a Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.02.2017 | ||
500 | |a Date Revised 21.03.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2016 Elsevier B.V. All rights reserved. | ||
520 | |a Inflammatory response plays an important role in the activation and progress of many debilitating diseases. Natural products, like cannabidiol, a constituent of Cannabis sativa, and moringin, an isothiocyanate obtained from myrosinase-mediated hydrolysis of the glucosinolate precursor glucomoringin present in Moringa oleifera seeds, are well known antioxidants also endowed with anti-inflammatory activity. This is due to a covalent-based mechanism for ITC, while non-covalent interactions underlie the activity of CBD. Since these two mechanisms are distinct, and the molecular endpoints are potentially complementary, we investigated in a comparative way the protective effect of these compounds alone or in combination on lipopolysaccharide-stimulated murine macrophages. Our results show that the cannabidiol (5μM) and moringin (5μM) combination outperformed the single constituents that, at this dosage had only a moderate efficacy on inflammatory (Tumor necrosis factor-α, Interleukin-10) and oxidative markers (inducible nitric oxide synthase, nuclear factor erythroid 2-related factor 2, nitrotyrosine). Significant upregulation of Bcl-2 and downregulation of Bax and cleaved caspase-3 was observed in cells treated with cannabidiol-moringin combination. Treatment with the transient receptor potential vanilloid receptor 1 antagonist was detrimental for the efficacy of cannabidiol, while no effect was elicited by cannabinoid receptor 1 and cannabinoid receptor 2 antagonists. None of these receptors was involved in the activity of moringin. Taken together, our in vitro results testify the anti-inflammatory, antioxidative, and anti-apoptotic effects of the combination of cannabidiol and moringin | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Anti-inflammation | |
650 | 4 | |a Cannabidiol | |
650 | 4 | |a Combination therapy | |
650 | 4 | |a LPS | |
650 | 4 | |a Macrophages | |
650 | 4 | |a Moringin | |
650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
650 | 7 | |a Antioxidants |2 NLM | |
650 | 7 | |a Apoptosis Regulatory Proteins |2 NLM | |
650 | 7 | |a Cytokines |2 NLM | |
650 | 7 | |a Isothiocyanates |2 NLM | |
650 | 7 | |a Lipopolysaccharides |2 NLM | |
650 | 7 | |a moringin |2 NLM | |
650 | 7 | |a Cannabidiol |2 NLM | |
650 | 7 | |a 19GBJ60SN5 |2 NLM | |
650 | 7 | |a isothiocyanic acid |2 NLM | |
650 | 7 | |a 3129-90-6 |2 NLM | |
650 | 7 | |a Nitric Oxide Synthase Type II |2 NLM | |
650 | 7 | |a EC 1.14.13.39 |2 NLM | |
650 | 7 | |a Nos2 protein, mouse |2 NLM | |
650 | 7 | |a EC 1.14.13.39 |2 NLM | |
700 | 1 | |a Giacoppo, Sabrina |e verfasserin |4 aut | |
700 | 1 | |a Iori, Renato |e verfasserin |4 aut | |
700 | 1 | |a De Nicola, Gina Rosalinda |e verfasserin |4 aut | |
700 | 1 | |a Grassi, Gianpaolo |e verfasserin |4 aut | |
700 | 1 | |a Pollastro, Federica |e verfasserin |4 aut | |
700 | 1 | |a Bramanti, Placido |e verfasserin |4 aut | |
700 | 1 | |a Mazzon, Emanuela |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Fitoterapia |d 1948 |g 112(2016) vom: 31. Juli, Seite 104-15 |w (DE-627)NLM106553100 |x 1873-6971 |7 nnns |
773 | 1 | 8 | |g volume:112 |g year:2016 |g day:31 |g month:07 |g pages:104-15 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.fitote.2016.05.008 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 112 |j 2016 |b 31 |c 07 |h 104-15 |